Analysis
Regulating prescription drugs for patient safety: Does Bill C-17 go far enough?
Matthew Herder, Elaine Gibson, Janice Graham, Joel Lexchin and Barbara Mintzes
CMAJ May 13, 2014 186 (8) E287-E292; DOI: https://doi.org/10.1503/cmaj.131850
Matthew Herder
Faculties of Medicine and Law (Herder), Health Law Institute, Dalhousie University; Schulich School of Law (Gibson), Dalhousie University; Department of Pediatrics (Graham), Faculty of Medicine, Dalhousie University, Halifax, NS; School of Health Policy and Management (Lexchin), York University; Emergency Department (Lexchin), University Health Network; Department of Family and Community Medicine (Lexchin), University of Toronto, Toronto, Ont.; School of Population and Public Health (Mintzes), University of British Columbia, Vancouver, BC
JSM LLMElaine Gibson
Faculties of Medicine and Law (Herder), Health Law Institute, Dalhousie University; Schulich School of Law (Gibson), Dalhousie University; Department of Pediatrics (Graham), Faculty of Medicine, Dalhousie University, Halifax, NS; School of Health Policy and Management (Lexchin), York University; Emergency Department (Lexchin), University Health Network; Department of Family and Community Medicine (Lexchin), University of Toronto, Toronto, Ont.; School of Population and Public Health (Mintzes), University of British Columbia, Vancouver, BC
LLMJanice Graham
Faculties of Medicine and Law (Herder), Health Law Institute, Dalhousie University; Schulich School of Law (Gibson), Dalhousie University; Department of Pediatrics (Graham), Faculty of Medicine, Dalhousie University, Halifax, NS; School of Health Policy and Management (Lexchin), York University; Emergency Department (Lexchin), University Health Network; Department of Family and Community Medicine (Lexchin), University of Toronto, Toronto, Ont.; School of Population and Public Health (Mintzes), University of British Columbia, Vancouver, BC
PhDJoel Lexchin
Faculties of Medicine and Law (Herder), Health Law Institute, Dalhousie University; Schulich School of Law (Gibson), Dalhousie University; Department of Pediatrics (Graham), Faculty of Medicine, Dalhousie University, Halifax, NS; School of Health Policy and Management (Lexchin), York University; Emergency Department (Lexchin), University Health Network; Department of Family and Community Medicine (Lexchin), University of Toronto, Toronto, Ont.; School of Population and Public Health (Mintzes), University of British Columbia, Vancouver, BC
MSc MDBarbara Mintzes
Faculties of Medicine and Law (Herder), Health Law Institute, Dalhousie University; Schulich School of Law (Gibson), Dalhousie University; Department of Pediatrics (Graham), Faculty of Medicine, Dalhousie University, Halifax, NS; School of Health Policy and Management (Lexchin), York University; Emergency Department (Lexchin), University Health Network; Department of Family and Community Medicine (Lexchin), University of Toronto, Toronto, Ont.; School of Population and Public Health (Mintzes), University of British Columbia, Vancouver, BC
PhD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Regulating prescription drugs for patient safety: Does Bill C-17 go far enough?
Matthew Herder, Elaine Gibson, Janice Graham, Joel Lexchin, Barbara Mintzes
CMAJ May 2014, 186 (8) E287-E292; DOI: 10.1503/cmaj.131850
Jump to section
Related Articles
- No related articles found.